Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial ...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by ...

Cognitive behavioral therapy (CBT) should be considered first-line treatment for generalized anxiety disorder in adults, according to a systematic review and network meta-analysis of 66 randomized ...

Anxiety disorders are among the most prevalent mental health conditions globally, affecting millions of individuals across various age groups. Characterized by persistent and excessive worry, fear, or ...

The last time I wrote about Mind Medicine (MindMed) Inc. (MNMD) was when it was gearing up to report results from a phase 2b study known as MMED008, which was using its drug MM120 for the treatment of ...

Some anxiety is part of the cost of admission to humanity. Because its distinguishing raison d’etre is the anticipation of bad outcomes, it can be a helpful stimulus to preparation or rehearsal before ...

LSD is a drug often associated with the counter-culture of the 1960s. But it is being studied as a promising therapy for anxiety in Charleston and the U.S.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. PsiGAD psilocybin-assisted therapy demonstrated a ...

Anxiety isn’t just about feeling stressed or worried. For millions of Americans it’s a daily battle that affects everything from relationships to career choices. With 31% of adults experiencing an ...

- Recently announced positive Phase 1 topline safety, pharmacokinetic (“PK”) and pharmacodynamic (“PD”) data show that intravenous (“IV”) CYB004 demonstrated robust and rapid-onset psychedelic effects ...